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Abstract 
 
BACKGROUND: The Appalachian Region faces multiple barriers to widespread 
COVID-19 vaccination. The purpose of this research study was to explore the role of 
trust in healthcare and trust in science on Appalachian residents’ readiness to receive 
the COVID-19 vaccine. Trust in health influencers and health information sources were 
also explored.  
METHODS: A cross sectional survey study of Appalachian Region residents (n=1048) 
was completed between February 25 and March 6, 2021, with equivalent rural and non-
rural sampling methods employed. Participants were >35 years of age and had not 
received the COVID-19 vaccine at the time of survey administration.  
RESULTS: Overall, 31% of participants were extremely likely to receive the vaccine, 
while 42% were somewhat likely/neither unlikely or likely/somewhat unlikely, and 27% 
were extremely unlikely. Based on multiple linear regression analysis with backwards 
selection, trust in healthcare, trust in science, residence (rural vs. non-rural) and age 
were positive predictors of readiness to receive the vaccine (F(5, 1042)= 38.9, R2= 
0.157, p< 0.01). Gender, education, household income, and political affiliation did not 
predict vaccine readiness. Trust in media for health information was modest, with 
ratings of none or not much for social media (64%), podcasts (61%), magazines (46%), 
radio (37%), newspapers (36%), and television (35%). Primary care providers emerged 
as the highest trusted health influencer of 15 options and a primary care provider’s 
office was the most common preference for location for receiving the COVID-19 
vaccine, particularly in participants who rated themselves as extremely unlikely to 
receive the COVID-19 vaccine.  
CONCLUSIONS: These findings suggest that trust in healthcare and science are 
prospective foci for initiatives aimed at improving vaccine acceptance in Appalachia, 
particularly in younger residents of rural areas. As highly trusted health influencers, 
primary care providers should be leveraged and supported in COVID-19 vaccine 
education and distribution.     
 
Keywords: primary care, family medicine, Appalachian region, health communication, 
influencer 
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Key Findings 
1. Compared with a 15% national average, 27% of this Appalachian Region cohort 
reported they were extremely unlikely to receive the COVID-19 vaccine.  
2. Trust in science and trust in healthcare were predictors of vaccine readiness and 
likelihood. 
3. Primary care providers were rated as the most trusted health influencer. Ratings 
of Dr. Anthony Fauci (NIH) were polarized as he was the second most trusted 
and also the least trusted health influencer. Second on the least trusted list was 
Dr. Sanjay Gupta (CNN). 
4. A primary care provider’s office was the preferred choice of location to receive 
the COVID-19 vaccine. Of those somewhat unlikely or extremely unlikely to 
receive the vaccine, 51% selected a primary care provider’s office as their 
preferred choice if they were to receive it. A primary care provider’s office was 
the preferred choice for COVID-19 vaccination even for participants without a 
personal primary care provider.  
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Introduction 
The Appalachian Region of the United States (population: 25 million) is 
comprised of 420 counties spanning 13 states (Alabama, Georgia, Kentucky, Maryland, 
Mississippi, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, 
Virginia, and West Virginia). Appalachia, which features unique mountain geography 
and a strong cultural history, also faces many health-related challenges, including 
greater rates of chronic disease, substance abuse, and mental health issues than other 
regions of the country.1 Socioeconomic disparities and inequities in healthcare access 
and quality are also prevalent.1-4  
The coronavirus disease 2019 (COVID-19) pandemic has brought 
unprecedented hardship to the Appalachian Region and has exacerbated existing 
challenges and vulnerabilities.5-12 Timely vaccination against COVID-19 is crucial to 
decrease its transmission, morbidity, and mortality, especially when paired with other 
public health strategies such as mask wearing and social distancing.13 However, a 
number of factors, including gender, age, race/ethnicity, education level, and political 
affiliation, influence COVID-19 vaccine hesitancy and resistance.14,15 Although 
incidence of and deaths from COVID-19 are greater among residents of rural areas, 
readiness to receive the vaccine is lower in these regions, despite controlling for other 
demographic factors.16 Rural regions also face numerous obstacles to vaccine 
distribution, potentially limiting access for even those who desire to receive it.17,18 
Trust in the health system, healthcare providers, and generalized trust are 
recognized as predictors of vaccine acceptance and uptake.19 Mistrust and distrust in 
government and science have been cited as early drivers of COVID-19 vaccine 
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hesitancy.14,20,21 In the United States, trust in the COVID-19 vaccine differs regionally 
and based on a variety of demographic factors.22 Minimal published data about the 
relationship between trust and vaccine readiness in Appalachia is available. The 
purpose of this study was to explore the concept of trust - in particular, trust in 
healthcare and trust in science - in relation to likelihood and readiness of receiving the 
COVID-19 vaccine in rural and non-rural residents of the Appalachian Region. A 
secondary aim was to describe trusted health influencers and health information 
sources among residents of the region.  
 
Methods 
A cross-sectional survey study of individuals residing in the Appalachian Region 
was conducted using Qualtrics Panels, an independent web-based, crowdsourced data 
collection company.23,24 Quota sampling methods were used to ensure that the sample 
was comprised of respondents who were 50% rural and 50% non-rural (Rural-Urban 
Continuum Code of 5-9 and 1-4, respectively) to match the overall population of the 
region. Additional survey inclusion criteria included: age >35 years, regular social media 
user (Facebook, Twitter, or Instagram at least weekly), and no history of receiving the 
COVID-19 vaccine and no appointment to do so at the time of survey administration. 
This study was considered exempt from human subjects review by the Institutional 
Review Board of [redacted] (IRB #[redacted]).      
 
Survey Tool and Survey Administration 
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 The survey required approximately 20 minutes to complete and was comprised 
of 40 questions in the following domains: 1) Demographics; 2) COVID-19 Experiences, 
Attitudes, Beliefs, and Desires; and Trust/Distrust in 3) Healthcare; 4) Science; and 5) 
COVID-19 Health Influencers and Information Sources. Likelihood of receiving the 
COVID-19 vaccine was measured on a 5-point Likert scale (extremely unlikely to 
extremely likely) and readiness to receive the vaccine was measured via a 9-point 
contemplation ladder (1= I have no thoughts or plans to receive the COVID-19 vaccine 
to 9= I am taking action to receive the COVID-19 vaccine). The Healthcare System 
Distrust Scale (HSDS)25 was used for #3, while #2, 4, and 5 were informed by existing 
published surveys.26-28 The selection of health influencers and information sources used 
in the survey was based on published literature, current social media trends, and 
feedback from three rounds of internal pilot testing.29-32  
Between February 25 and March 6, 2021, registered Qualtrics panelists were 
recruited via email or social media to participate in the survey using recruitment 
procedures and consenting processes standard to Qualtrics Panels surveys.33 Those 
who consented to participate proceeded with the survey. No personal identifiers were 
collected by the research team. Approximate sample size was informed by a priori 
power analysis, allowing 80% power to detect a small effect size or larger in multiple 
linear regression.  
A “soft launch” was administered to approximately 5% of the target sample size 
on February 22, 2021 to check the survey for unexpected errors or omissions. As no 
changes were made to the survey after the soft launch (with the exception of the 
addition of one CAPTCHA question), soft launch responses (n= 56) were included in the 
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final sample. If participants did not complete the entire survey, failed the attention 
check, demonstrated straightlining behavior (i.e., response patterns indicative of 
inattention), provided nonsensical or irrelevant responses to the two open-ended 
questions, or completed the survey in an unusually slow or fast manner, their responses 
were excluded from the final sample using standard Qualtrics procedures. 
 
Statistical Analysis  
 Data were analyzed using IBM SPSS version 26.0. Descriptive data are 
expressed as means + standard deviation. Within-variable differences were evaluated 
via one-way ANOVA or chi-square analysis and relationships between variables were 
explored using Spearman’s correlation analysis. Multiple linear regression was used to 
evaluate the association between distrust in healthcare and distrust in science on 
readiness to receive the COVID-19 vaccine. Additional demographic predictors included 
region of primary residence (rural and non-rural), age, gender, race, ethnicity, 
education, annual income (household), and political affiliation. Backwards selection was 
used to determine which subset of predictors to include in the final model. Alpha was 
set at .05 for all analyses.   
 
Results 
Selected results focused on trust are presented in this brief report, with some 
additional findings included in the Supplemental Data. Of the 2,616 panelists who 
expressed interest in participating, 91 failed to provide consent, 1,149 did not meet 
inclusion criteria, and another 419 were excluded from data analysis, leaving a final 
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sample of n=1048. Demographic characteristics of the participants and their COVID-19 
vaccine likelihood and readiness are shown in Table 1.  
 
Trust 
Total score on the HSDS was 26.1 + 6.3 on a scale of 9 to 45 (higher score = 
greater distrust) (full results available in Supplemental Data). Participants rated their 
trust in science as none (1%), not much (12%), some (52%), and a lot (35%). Trust in 
science produced by universities was rated as none or not much by 18% of participants, 
compared with 43% for science produced by the government, 31% for science 
produced by the medical or pharmaceutical industry, and 15% for scientists themselves.  
The optimal linear regression model, as identified through backwards model 
selection, included distrust in healthcare, distrust in science, residence (rural vs. non-
rural), and age as predictors of readiness to receive the COVID-19 vaccine (F(5, 1042)= 
38.9, R2= 0.157, p< 0.01). Individual predictors are provided in Table 2. Specifically, 
greater vaccine readiness was associated with greater distrust in science and 
healthcare, older age, rural residence, and more education. 
             Participants’ trust in various news sources for health information about COVID-
19 is rated highest for television, with 24% indicating a lot of trust (Figure 1). In contrast, 
trust ratings of none or not much were given for social media by 64% participants and 
for podcasts by 61% participants. In terms of trust in health influencers for information 
about COVID-19, the greatest number of participants (47%) rated a lot of trust in their 
primary care provider (Table 3). When asked which health influencer they trusted the 
most from a list of 15 options, 34% responded with “my primary care provider”, 18% 
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with “Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious 
Disease”, and 10% with the “Centers for Disease Control (CDC)”. Remaining health 
influencers were rated as most trusted by less than 5% of participants. The least trusted 
health influencers were Dr. Fauci (24%), Dr. Sanjay Gupta, CNN Chief Medical 
Correspondent (15%), and Dr. Scott Atlas, Former Senior Health Advisor to President 
Trump (13%), and the World Health Organization (WHO) (12%), with remaining health 
influencers rated least trusted by less than 7% of participants.  
 
COVID-19 
 Overall, 27% participants rated themselves as extremely unlikely to get the 
vaccine, while 31% were extremely likely, and 42% were either somewhat unlikely, 
neither unlikely or likely, or somewhat likely (Figure 2). Vaccine likelihood and readiness 
were positively correlated (r= 0.828, p<0.001) (Figure 2).  
A total of 40% of participants rated a primary care provider’s office as their 
preferred location to receive the COVID-19 vaccine if they were to receive it; 21% had 
no preference in locations (Figure 3). Of participants extremely unlikely or somewhat 
unlikely to receive the COVID-19 vaccine, 51% rated primary care provider’s office as 
their preferred location if they were to receive it. There was no difference between 
preferred vaccine location in rural and non-rural residents. 
Participants’ ratings of fears and concerns related to COVID-19 and the COVID-
19 vaccine are shown in the Supplemental Data. Fear that that friends and family 
members will die from COVID-19 was rated as some or a lot by 51% of participants. 
Long-term safety of the vaccine and side effects of getting the vaccine were the highest 
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reported vaccine-related concerns (65% and 65% rating some or a lot, respectively). 
Thirty-seven percent of participants rated their concern about access to the vaccine as 
none and 53% rated their concern about cost of the vaccine to them as none. There 
were no differences between rural and non-rural participants in ratings of fear and 
concerns.  
 
Primary care 
 There were 847 (81%) participants who reported having a primary care provider. 
Some or a lot of trust in “my primary care provider” was reported by 92% of participants. 
Those with a primary care provider were older (56.0 vs. 50.6 years) more likely to be 
female (59% vs. 54%), of higher income (25% vs. 36% earning <$20,000 annually and 
18% vs. 10% earning >$80,000 annually), and rated greater trust in healthcare (HSDS 
score of 25.1 vs. 27.1) (p< 0.05) than those without a primary care provider. The highest 
ranked preferred location to receive the COVID-19 vaccine by participants without a 
personal primary care provider was “a primary care provider’s office”. 
 
Discussion  
 The Appalachian Region has been disproportionately impacted by COVID-19 
and downstream effects of COVID-19. To date, COVID-19 vaccine uptake in Appalachia 
has trailed other parts of the country, in spite of early success in West Virginia.34 
Distrust in science and healthcare were associated with lower readiness to receive the 
COVID-19 vaccine. Residing in a rural area was also associated with reduced vaccine 
readiness, which replicates recent findings.16 The White House recently announced a 
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substantial investment to improve vaccine access and build confidence among high-risk 
communities across the United States, including Appalachia.35 Efforts to acknowledge 
the regional historical, cultural, and social foundations of existing distrust, while 
leveraging trusted health influencers and communication sources will be instrumental to 
the success of this investment throughout the region, particularly in rural Appalachia 
where readiness to receive the COVID-19 vaccine is the lowest.  
Participants’ trust in primary care providers emerged as a predominant theme of 
the study. Others have also highlighted the importance of primary care providers in 
COVID-19 vaccine education, counseling, and administration.36-38 Further research is 
needed to understand this trust, which could be attributed to familiarity, access, 
individual healthcare concerns in light of new vaccine technology, and/or the importance 
of established relationships in navigating complex decisions. Given the importance of 
strong relationships and sense of place on subjective meanings of healthcare in the 
region and the cultural beliefs of health as holistic in nature,39 it is perhaps unsurprising 
that primary care providers, with whom residents might feel they could build personal 
relationships, were overwhelmingly preferred as a site of vaccination than large clinics, 
hospitals, or workplaces. Primary care, especially in rural areas, has been hit hard by 
the pandemic;40,41 enhancing resources to support primary care providers and their 
unique role in COVID-19 vaccine acceptance is warranted.   
 
Conclusion 
   This study was a first step in improving understanding of factors that influence 
COVID-19 vaccine readiness in Appalachia. Trust in science and trust in healthcare 
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were important predictors of vaccine readiness in this region, as were age and non-rural 
residence. Primary care providers were identified as highly trusted vaccine influencers, 
while other influencers, especially those representing the government, received highly 
variable or poor trust ratings. Further research is needed to identify sub-regional 
variation in these factors, methods to enhance access and trust, and strategies to 
diffuse misinformation and distrust among Appalachian Region residents. 
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Table 1. Demographic Characteristics of Participants Residing in Rural and Non-Rural Settings in 
the Appalachian Region 
 
 
 
RURAL 
n (%) 
NON-RURAL 
n (%) 
n 524 (50) 524 (50) 
Appalachian Sub-Region Northern: 100 (19) 
North Central: 89 (17) 
Central: 106 (20) 
South Central: 96 (18) 
Southern: 133 (25) 
Northern: 94 18) 
North Central: 112 (21) 
Central: 81 (15) 
South Central: 101 (19) 
Southern: 136 (26) 
Age (years) 35-44: 126 (24) 
45-54: 121 (23) 
55-64: 147 (28) 
65-74: 110 (21) 
    >75: 20 (4) 
35-44: 118 (23) 
45-54: 127 (24) 
55-64: 147 (28) 
65-74: 119 (23 
>75: 13 (2) 
Gender  Male: 200 (38) 
Female: 301 (57) 
Other: 23 (4) 
Male: 201 (38) 
Female: 306 (58) 
Other: 17 (3) 
Race White/Caucasian: 484 (92) 
Black/African American: 15 (3) 
Asian: 3 (1) 
Other: 22 (4) 
White/Caucasian: 483 (93) 
Black/African American: 22 (4) 
Asian: 3 (1) 
Other: 16 (3) 
Ethnicity Hispanic/Spanish/Latinx: 22 (4) 
Non-Hispanic/Spanish/Latinx: 502 (96) 
Hispanic/Spanish/Latinx: 34 (6) 
Non-Hispanic/Spanish/Latinx: 490 (94) 
Education High school or less: 219 (42) 
Some college or college degree: 269 (51) 
Graduate or professional degree: 36 (7) 
High school or less: 180 (34) **       
Some college or college degree: 281 (54) 
Graduate or professional degree: 63 (12)  
Household Income (annual) <$20,000: 155 (30) 
$20,000 to $79,999: 295 (56) 
$80,000 to $169,999: 64 (12) 
>$170,000: 10 (2) 
<$20,000: 123 (23) ** 
$20,000 to $79,999: 304 (58) 
$80,000 to $169,999: 85 (16) 
>$170,000: 12 (2) 
Political Affiliation Republican: 251 (48) 
Democrat: 115 (22) 
Independent: 115 (22) 
Republican: 200 (38) ** 
Democrat: 139 (27) 
Independent: 142 (27) 
Political Ideology (1 to 9, with 
1=extremely conservative, 
5=moderate, 9=extremely liberal) 
3.9 + 1.7 4.1 + 2.0 
History of positive COVID-19 test (yes) 83 (16) 47 (9) 
Friends/family members with a 
positive COVID-19 test 
3.4 + 4.9 2.6 + 3.8 ** 
Likelihood of Getting COVID-19 
Vaccine a 
Extremely unlikely: 146 (28) 
Somewhat unlikely: 59 (11) 
Neither unlikely or likely: 75 (14) 
Somewhat likely: 81 (15) 
Extremely likely: 163 (31) 
Extremely unlikely: 132 (25) 
Somewhat unlikely: 58 (11) 
Neither unlikely or likely: 75 (14) 
Somewhat likely: 89 (17) 
Extremely likely: 170 (32) 
COVID-19 Vaccine Readiness b 4.5 + 3.3 4.9 + 3.3 ** 
 
aIf a FDA-approved COVID-19 vaccine were available to you today at no cost, would you accept it? 
 
bEach rung on the ladder represents where people are thinking about getting the COVID-19 vaccine. Move the sliding scale on the 
right to the number that best represents where you are now. (1= I have no thoughts or plans to get the COVID-19 vaccine, 9= I am 
taking action to receive the COVID-19 vaccine). 
**= p< 0.01 
  
18 
This article is a preprint and has not been peer reviewed. It reports new medical research or thought that has yet to be evaluated 
and so should not be used to guide clinical practice. Copyright ©2021 by Michelle Rockwell. Posted on Annals of Family Medicine 
COVID-19 Collection, courtesy of Michelle Rockwell. 
Table 2. Association Between Distrust in Healthcare and Distrust in Science on Readiness to 
Receive the COVID-19 Vaccine: Multiple Linear Regression Final Model 
 
Predictor 
Standardized 
Beta value 
t p value 
Distrust in Science -0.305 -10.164   0.000 ** 
Distrust in Healthcare -0.139  -4.692   0.000 ** 
Age  0.092   3.195   0.001 ** 
Residence (rural vs. non-rural)  0.058   2.016   0.044 * 
Education  0.056   1.936   0.053 
  
Dependent variable = Readiness to receive the COVID-19 vaccine (contemplation ladder);  Removed from model through 
backwards selection = gender, race, ethnicity, annual income (household), and political affiliation;  To aid in interpretation of results 
and consistent ordering of trust measures, participants’ ratings of trust in science were reverse scored, allowing quantifica tion of 
distrust in science;  * = p<0.05, ** = p<0.01. 
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Table 3. Ratings of Trust in Health Influencers Regarding COVID-19 Information 
 
Health Influencer 
 
Not sure 
 
 
None 
 
 
Not Much 
 
 
Some 
 
 
A lot 
 
My primary care provider 8% 5% 10% 30% 47% 
Centers for Disease Control (CDC) 7% 16% 17% 31% 30% 
Physician in My Region 11% 7% 15% 40% 28% 
Dr. Anthony Fauci, Director of the National 
Institute of Allergy and Infectious Disease 
10% 32% 11% 19% 28% 
Hospital or Health System in My Region 8% 11% 17% 39% 25% 
Nurse in My Region 11% 9% 16% 42% 22% 
My Local Health Department 7% 10% 20% 42% 20% 
World Health Organization (WHO) 12% 29% 16% 24% 19% 
Dr. Sanjay Gupta, CNN Chief Medical 
Correspondent 
20% 24% 16% 23% 16% 
Community Health Worker in My Region 14% 11% 22% 39% 14% 
Dr. Valerie Fitzhugh, Chair of Pathology at 
Rutgers University, COVID-19 Vaccine Trial 
Participant 
31% 18% 15% 23% 13% 
Dr. Mehmet Oz, Professor at Columbia 
University, Host of the Dr. Oz Show 
14% 30% 22% 22% 12% 
Dr. Jane Orient, Director of the Association of 
American Physicians, Testified to Congress 
Against COVID-19 Vaccine 
31% 23% 15% 21% 11% 
Dr. Scott Atlas, Former Senior Health Advisor 
to President Trump 
24% 30% 16% 20% 10% 
Dr. Marc Seigel, Fox News Chief Medical 
Correspondent 
27% 28% 16% 21% 9% 
 
The order of information sources and health influencers was randomized in the survey with the exception of “a physician in my 
region”, which was programmed to always occur after “my primary care provider” in the list. 
20 
This article is a preprint and has not been peer reviewed. It reports new medical research or thought that has yet to be evaluated 
and so should not be used to guide clinical practice. Copyright ©2021 by Michelle Rockwell. Posted on Annals of Family Medicine 
COVID-19 Collection, courtesy of Michelle Rockwell. 
Figure 1. Ratings of Trust in New Sources for Health Information Related to COVID-19 
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Figure 2. Likelihood of and Readiness to Receive the COVID-19 Vaccine 
 
 
Vaccine Likelihood: If an FDA-approved, no-cost COVID-19 vaccine was available to you today, how likely would you be to get 
vaccinated?
  
 
Vaccine Readiness: Each rung in this ladder represents where various people are in their thinking about getting the COVID-19 
vaccine. Move the sliding scale on the right to the number that best represents where you are now.a 
 
 
 
1= I have no thoughts or plans to get the COVID-19 vaccine. 
5= I think I should get the COVID-19 vaccine, but I am not ready. 
Mean: 4.2 
Standard Deviation: 3.1 
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9= I am taking action to receive the COVID-19 vaccine. 
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Figure 3. Preferred Location to Receive the COVID-19 Vaccine  
 
 
If you were to receive the COVID-19 vaccine, where would be your first choice to receive it? 
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Supplemental Data 
 
 
Healthcare System Distrust Scale (HSDS)- Questions 
 
 
Question 
Strongly 
Disagree 
n (%) 
Disagree 
n (%) 
Not Sure 
n (%) 
Agree 
n (%) 
Strongly 
Agree 
n (%) 
 
The Health Care System covers up its 
mistakes.  
33 (3) 93 (9) 432 (41) 346 (33) 
 
142 (13) 
 
The Health Care System makes too many 
mistakes.  
49 (5) 219 (21) 460 (44) 238 (23) 
 
81 (8) 
 
The Health Care System puts making 
money above patients’ needs. 
41 (4) 141 (14) 316 (30) 337 (32) 
 
212 (20) 
 
The Health Care System lies to make 
money. 
71 (7) 194 (19) 409 (39) 261 (25) 
 
112 (11) 
 
The Health Care System experiments on 
patients without them knowing. 
126 (12) 271 (26) 393 (38) 180 (17) 
 
77 (7) 
 
Strongly 
Agree 
n (%) 
Agree 
n (%) 
Not Sure 
n (%) 
Disagree 
n (%) 
Strongly 
Disagree 
n (%) 
 
The Health Care System does its best to 
make patients’ health better. 
160 (15) 571 (55) 202 (19) 82 (8) 
 
32 (3) 
 
Patients receive high quality medical care 
from the Health Care System. 
95 (9) 493 (47) 300 (29) 124 (12) 
 
36 (3) 
 
The Health Care System gives excellent 
medical care. 
79 (8) 458 (44) 337 (32) 137 (13) 
 
35 (3) 
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Fears related to COVID-19 
 
To what extent have you felt fear about 
the following in the past week: 
None 
n (%) 
A Little 
n (%) 
Some 
n (%) 
A Lot 
n (%) 
 
Getting COVD-19 
 
334 (32) 302 (29) 226 (22) 186 (18) 
 
Getting sick from COVID-19 
 
307 (29) 264 (25) 243 (23) 234 (22) 
 
Being hospitalized due to COVID-19 
 
348 (33) 255 (24) 236 (23) 209 (20) 
 
Dying due to COVID-19 
 
443 (42) 256 (24) 191 (18) 158 (15) 
 
Friends or family members dying due to 
COVID-19 
214 (20) 302 (29) 260 (25) 272 (26) 
 
Doing something that will cause someone 
else to get COVID-19 
439 (42) 305 (29) 185 (18) 119 (11) 
 
Loss of employment or income due to 
COVID-19 
566 (54) 192 (18) 154 (15) 136 (13) 
 
Being judged due to precautions I take due 
to COVID-19 
669 (67) 174 (17) 110 (11) 65 (6) 
 
 
Concerns Related to the COVID-19 Vaccine 
How concerned are you about the 
following issues related to the COVID-
19 vaccine? 
None 
n (%) 
A Little 
n (%) 
Some 
n (%) 
A Lot 
n (%) 
 
The speed at which the vaccine was 
developed. 
221 (21) 239 (23) 236 (23) 352 (34) 
 
The effectiveness of the vaccine. 
200 (19) 235 (22) 302 (29) 311 (30) 
 
The short-term safety of the vaccine. 
194 (19) 237 (23) 265 (25) 352 (34) 
 
The long-term safety of the vaccine. 
153 (15) 212 (20) 250 (24) 433 (41) 
 
Side effects of the vaccine. 
147 (14) 224 (21) 246 (24) 431 (41) 
 
Politics around the development of the 
vaccine. 
217 (21) 199 (19) 246 (24) 386 (37) 
 
My access to getting the vaccine.  
392 (37) 232 (21) 237 (23) 187 (18) 
 
Access of vulnerable friends and loved 
ones to getting the vaccine.  
270 (26) 263 (25) 262 (25) 253 (24) 
 
The cost of the vaccine to me.  
559 (53) 174 (17) 146 (14) 169 (16) 
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